National Institutes of Health state-of-the-science conference statement: Preventing Alzheimer disease and cognitive decline

Annals of Internal Medicine

Volumn 153, Issue 3, 2010, Pages 176-181

  Daviglus, Martha L ^a   Bell, Carl C ^b   Berrettini, Wade ^c   Bowen, Phyllis E ^b   Connolly Jr , E Sander ^d   Cox, Nancy Jean ^e   Dunbar Jacob, Jacqueline M ^f   Granieri, Evelyn C ^g   Hunt, Gail ^h   McGarry, Kathleen ⁱ   Patel, Dinesh ^j   Potosky, Arnold L ^k   Sanders Bush, Elaine ^l   Silberberg, Donald ^m   Trevisan, Maurizio ⁿ  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g University of Pittsburgh ^*  (United States)

^h National Alliance for Caregiving   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Hebrew Home of Greater Washington   (United States)

^k GEORGETOWN UNIVERSITY   (United States)

^l VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ Health Sciences System   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ASCORBIC ACID; BETA CAROTENE; CELECOXIB; CHOLINESTERASE INHIBITOR; CONJUGATED ESTROGEN; CYANOCOBALAMIN; FLAVONOID; GINKGO BILOBA EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEDROXYPROGESTERONE; MULTIVITAMIN; NAPROXEN; OMEGA 3 FATTY ACID; ROFECOXIB;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DEMENTIA; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG WITHDRAWAL; EMOTIONAL STABILITY; HEREDITY; HUMAN; LOW DRUG DOSE; NATIONAL HEALTH ORGANIZATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK REDUCTION; SMOKING; SOCIAL ASPECT; SOCIOECONOMICS; VITAMIN SUPPLEMENTATION; AGED; EVIDENCE BASED MEDICINE; RISK FACTOR;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; EVIDENCE-BASED MEDICINE; HUMANS; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 77955487508     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-3-201008030-00260     Document Type: Conference Paper

References (0)